Literature DB >> 17921868

The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells.

Athanasia Warnecke1, Kirsten Wissel, Andrea Hoffmann, Nicola Hofmann, Nurdanat Berkingali, Gerhard Gro, Thomas Lenarz, Timo Stöver.   

Abstract

The benefit achieved by the use of cochlear implants depends among other factors on the number of surviving spiral ganglion cells (SGCs). Neurotrophic factors, especially brain-derived neurotrophic factor (BDNF), have a protective effect on spiral ganglions. Coating of the cochlear implant electrode with BDNF-producing cells may provide long-term delivery of the factor. Therefore, the hypothesis that BDNF-producing fibroblasts can enhance cell survival of cultured SGCs was tested. Lentiviral infection of fibroblasts resulted in BDNF production. Conditioned medium obtained from infected fibroblasts was used for the cultivation of SGCs. As a result, improved survival and neurite outgrowth was observed on SGCs. Our results demonstrate that lentivirally infected fibroblasts produce BDNF that has neurotrophic effects on spiral ganglions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17921868     DOI: 10.1097/WNR.0b013e3282f0b5d7

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

1.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Authors:  Patricia A Leake; Stephen J Rebscher; Chantale Dore'; Omar Akil
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-20

Review 2.  Intracochlear drug delivery systems.

Authors:  Jeffrey T Borenstein
Journal:  Expert Opin Drug Deliv       Date:  2011-05-26       Impact factor: 6.648

3.  Brain-derived neurotrophic factor promotes cochlear spiral ganglion cell survival and function in deafened, developing cats.

Authors:  Patricia A Leake; Gary T Hradek; Alexander M Hetherington; Olga Stakhovskaya
Journal:  J Comp Neurol       Date:  2011-06-01       Impact factor: 3.215

Review 4.  Drug delivery for treatment of inner ear disease: current state of knowledge.

Authors:  Andrew A McCall; Erin E Leary Swan; Jeffrey T Borenstein; William F Sewell; Sharon G Kujawa; Michael J McKenna
Journal:  Ear Hear       Date:  2010-04       Impact factor: 3.570

5.  Localized cell and drug delivery for auditory prostheses.

Authors:  Jeffrey L Hendricks; Jennifer A Chikar; Mark A Crumling; Yehoash Raphael; David C Martin
Journal:  Hear Res       Date:  2008-06-07       Impact factor: 3.208

6.  Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.

Authors:  Patricia A Leake; Olga Stakhovskaya; Alexander Hetherington; Stephen J Rebscher; Ben Bonham
Journal:  J Assoc Res Otolaryngol       Date:  2013-02-08

7.  Characterization of neuronal cell death in the spiral ganglia of a mouse model of endolymphatic hydrops.

Authors:  Maroun T Semaan; Qing Y Zheng; Fengchan Han; Yuxi Zheng; Heping Yu; John C Heaphy; Cliff A Megerian
Journal:  Otol Neurotol       Date:  2013-04       Impact factor: 2.311

8.  A Genetic Murine Model of Endolymphatic Hydrops: The Phex Mouse.

Authors:  Cameron C Wick; Maroun T Semaan; Qing Yin Zheng; Cliff A Megerian
Journal:  Curr Otorhinolaryngol Rep       Date:  2014-09

9.  Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.

Authors:  Omar Akil; Bas Blits; Lawrence R Lustig; Patricia A Leake
Journal:  Hum Gene Ther       Date:  2018-09-05       Impact factor: 5.695

10.  Neuronal Survival, Morphology and Outgrowth of Spiral Ganglion Neurons Using a Defined Growth Factor Combination.

Authors:  Jana Schwieger; Athanasia Warnecke; Thomas Lenarz; Karl-Heinz Esser; Verena Scheper
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.